Amarantus Bioscience Holdings Inc. announced the appointment of Mr. Iain Ross to the Company's Board of Directors, Mr. Ross brings over 30 years of biopharmaceutical industry experience to Amarantus across executive management, investment and directorship roles. Currently he is Chairman of the Board of Ark Therapeutics Group PLC and Biomer Technology Ltd, and is also a Non-Executive Director of Benitec Biopharma Limited, Novogen Limited and Tissue Therapies Ltd. each of which is traded on the Australian Securities Exchange.